Trending...
- The Simplest Small Business You're Probably Not Thinking About
- Kevin "Mr. Wonderful" O'Leary Begins New Universal Coin & Bullion Promotion of Gold and Silver
- American Mensa and Davidson Institute Join Forces To Strengthen Support for Profoundly Gifted Youth
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
The firm urges investors in LifeMD who suffered significant losses to submit your losses now.
Class Period: May 7, 2025 – Aug. 5, 2025
Lead Plaintiff Deadline: Oct. 27, 2025
Visit: www.hbsslaw.com/investor-fraud/lfmd
Contact the Firm Now: [email protected]
844-916-0895
LifeMD, Inc. (LFMD) Securities Class Action:
The lawsuit, captioned Johnston v. LifeMD, Inc., focuses on the period between May 7 and August 5, 2025. It alleges that LifeMD made false and misleading statements, particularly on May 6, 2025, when it reported its first-quarter results and raised its full-year revenue and adjusted EBITDA guidance. The complaint claims that the company's optimistic outlook, which cited a "category-defining competitive moat" in virtual obesity care and strong performance from its RexMD brand, was false as it misleadingly failed to account for crucial business challenges.
More on Nyenta.com
The suit contends that LifeMD was experiencing rising customer acquisition costs in its RexMD segment and a higher-than-anticipated refund rate in its weight management business, issues that it did not disclose to investors at the time.
The alleged deception unraveled on August 5, 2025, when LifeMD announced its second-quarter results, missing revenue and earnings per share estimates and subsequently slashing its full-year guidance. During the earnings call, management cited "temporary elevated customer acquisition costs" for its RexMD business and issues with patient refunds for its weight management offerings. The following day, LifeMD's stock price plummeted by over 44%.
For investors who suffered substantial losses during this period, the lawsuit represents an opportunity to recover damages.
Hagens Berman's Investigation
Hagens Berman, a national plaintiffs' rights firm, is investigating these claims.
"We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in LifeMD and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the LifeMD case and our investigation, read more »
More on Nyenta.com
Whistleblowers: Persons with non-public information regarding LifeMD should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
SOURCE Hagens Berman Sobol Shapiro LLP
The firm urges investors in LifeMD who suffered significant losses to submit your losses now.
Class Period: May 7, 2025 – Aug. 5, 2025
Lead Plaintiff Deadline: Oct. 27, 2025
Visit: www.hbsslaw.com/investor-fraud/lfmd
Contact the Firm Now: [email protected]
844-916-0895
LifeMD, Inc. (LFMD) Securities Class Action:
The lawsuit, captioned Johnston v. LifeMD, Inc., focuses on the period between May 7 and August 5, 2025. It alleges that LifeMD made false and misleading statements, particularly on May 6, 2025, when it reported its first-quarter results and raised its full-year revenue and adjusted EBITDA guidance. The complaint claims that the company's optimistic outlook, which cited a "category-defining competitive moat" in virtual obesity care and strong performance from its RexMD brand, was false as it misleadingly failed to account for crucial business challenges.
More on Nyenta.com
- T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
- L'Atelier Paris Introduces Le Linéaire During NYCxDESIGN 2026
- NYC Buyers Are Relocating To Westchester At Accelerating Pace In 2026, Says Local Realtor
- The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
- VConnect USA LLC Launches Dedicated B2B and B2C Commerce Platforms
The suit contends that LifeMD was experiencing rising customer acquisition costs in its RexMD segment and a higher-than-anticipated refund rate in its weight management business, issues that it did not disclose to investors at the time.
The alleged deception unraveled on August 5, 2025, when LifeMD announced its second-quarter results, missing revenue and earnings per share estimates and subsequently slashing its full-year guidance. During the earnings call, management cited "temporary elevated customer acquisition costs" for its RexMD business and issues with patient refunds for its weight management offerings. The following day, LifeMD's stock price plummeted by over 44%.
For investors who suffered substantial losses during this period, the lawsuit represents an opportunity to recover damages.
Hagens Berman's Investigation
Hagens Berman, a national plaintiffs' rights firm, is investigating these claims.
"We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in LifeMD and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the LifeMD case and our investigation, read more »
More on Nyenta.com
- Renisis Wins National Jewelry Competition
- Monticello Equipment Named Authorized Forklift Dealer for LiuGong North America
- $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH
- All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
- iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
Whistleblowers: Persons with non-public information regarding LifeMD should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
SOURCE Hagens Berman Sobol Shapiro LLP
Filed Under: Business
0 Comments
Latest on Nyenta.com
- N Y S E: OTH Off The Hook YS Is Building a Vertically Integrated Marine Empire — And Investors Are Starting to Notice
- Concierge Title Agency Merges with Independence Title, Inc. to Deliver an Expanded Concierge Closing Experience Across South Florida
- New Data: Female Athletes Now Dominate Sports Brand Deals as OpenSponsorship Releases 2026 Marketing Report
- Grow My Security Company Launches Next-Generation Website and Expands Strategic Marketing Solutions for the Security Industry
- $4.8M in Contracted AI Revenue with Projections of $30M Over 6-12 Months for Diversified AI Software and Platform-Based Services Provider XMax Inc
- Michelangelo's Great Secret Hiding in Plain Sight
- Virginia Marchese's Paradox: A Nation Still Deciding Who Belongs Examines Race, Migration, Law, and America's Unfinished Struggle for Equality
- From Blank Page to Published Book
- Larry R. Wasion's Jump Gate III RoadMaker Blends Cutting-Edge Sci-Fi with High-Stakes Space Exploration and Complex Technologies
- Tabpro Solutions Named to Two Forbes 2026 Best Recruiting Firms Lists
- Boom•Clap Expands Affordable Access for Independent Creatives and Grassroots Organizations
- American Mensa and Davidson Institute Join Forces To Strengthen Support for Profoundly Gifted Youth
- 16th Annual Art Of Brooklyn Film Fest Returns June 1-10 with 55 New Indies
- 360 Sound And Vision Releases The Ubiquitous Compact Disc and America's Most Deadly UFO Encounters
- SpeedyIndex Rolls Out Automated API for Mass URL Verification, Solving the Backlink Blind Spot for SEO Agencies
- KLEKT Announces Appointment of Jay Kimpton to Board of Directors
- Michigan Attorney General Closed FGM Licensing Investigations Months Before Federal Case Ended, Records Show
- Mensa Foundation Event Reframes Brain Health for Every Age
- DLT Resolution, Inc. (Stock Symbol: DLTI) Expands Into the $224 Billion Life Settlements Market While Accelerating Telecom Growth Across Canada
- onSpark Launches an AI-Driven Operating System for the $200B Partnership Economy